New 52-Week Low Could Prompt More Insider Buying At ROG

In trading on Tuesday, shares of Rogers Corp. ( ROG) touched a new 52-week low of $55.80/share. That's a $12.54 share price drop, or -18.35% decline from the 52-week high of $68.34 set back on 07/02/2014. Large percentage drops always require that the stock post even larger percentage gains from the low in order to recover the old price point, and for ROG that means the stock would have to gain 22.47% to get back to the 52-week high. For a move like that, Rogers Corp. would need fundamental strength at the business level.

Here's a rhetorical question: Who knows more about fundamentals at the business level than the company's own insiders? So let's take a look to see whether any company insiders were taking the other side of the trade as ROG shares were being sold down to this new 52-week low, focusing on the most recent trailing six month period. As summarized by the table below, ROG has seen 3 different instances of insiders buying over the past six months.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
05/22/2014 Bruce D. Hoechner President and CEO 335 $59.90 $20,066.50
05/22/2014 Bruce D. Hoechner President and CEO 80 $60.02 $4,801.60
07/31/2014 David Mathieson Vice President & CFO 866 $57.76 $50,016.18
07/31/2014 Bruce D. Hoechner President and CEO 850 $58.81 $49,985.10
07/31/2014 Gary M. Glandon VP, and Chief HR Officer 500 $58.13 $29,065.50

In the short run, while the new 52-week low suggests the stock is at the cheapest price and perhaps therefore the best bargain it has been over the last 52 weeks, the low print also means anyone who has purchased the stock over that timeframe is staring at an unrealized loss. Oftentimes, that factor drives a stock's technical analysis metrics by creating overhead resistance, with investors who bought higher now anxious to reverse their trade once they are back to breakeven. The chart below shows where ROG has traded over the past year, with the 50-day and 200-day moving averages included.

Rogers Corp. Moving Averages Chart

Time will tell whether the insider purchases foretell a future rebound for ROG shares, which are presently showing a last trade of $56.04/share, slightly above the new 52-week low.

If you liked this article you might like

FDA Approves First 'Biosimilar' for Cancer Treatment

FDA Approves First 'Biosimilar' for Cancer Treatment

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

5 New Breast Cancer Treatments That Are Helping to Save Lives

5 New Breast Cancer Treatments That Are Helping to Save Lives

Celgene Enters PD1 Market with BeiGene Deal

Celgene Enters PD1 Market with BeiGene Deal

Epizyme's Positive Cancer Drug Results Likely to Catch the Eye of Celgene, J&J

Epizyme's Positive Cancer Drug Results Likely to Catch the Eye of Celgene, J&J